More than 20 respiratory conditions could receive extra financial support from PIP to help with daily living costs ...

Search Engine Land » SEO » Search Engine Land’s Guide To All Things Search » What Is SEO – Search Engine Optimization? Chat with SearchBot Please note that your conversations will be ...

Itepekimab is under development for the treatment of chronic obstructive pulmonary disease, non-cystic fibrosis bronchiectasis. It is administered intravenously and subcutaneously. The drug candidate ...

Indiana University School of Medicine researchers have uncovered compelling evidence that children with primary ciliary ...

The list includes a number of common respiratory health conditions such as asthma, pneumonia, sleep apnoea and chronic ...

Asthma, pneumonia and over 20 other conditions affecting the lungs and respiratory system are supported by PIP.

CYCLING fundraiser Gerard McCarten travelled to Surrey to meet with Debbie Clarke of The Macular Society. The meeting had been a long time in the making having first met on the phone many months ...

Explore the latest research on Aspergillus in bronchiectasis, uncovering its prevalence, clinical significance, and potential ...

The bronchiectasis market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM bronchiectasis market size from 2020 to 2034 ...

The NCFB market in the 7 Major Markets was valued at approximately USD 1.45 billion in 2023. Over the forecast period from 2024 to 2034, this market is projected to grow at a CAGR of 14.5%.Dublin, Dec ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), RTX Corp.

Discover how asthma contributes to bronchiectasis development through sinusitis and inflammation. Learn about new findings ...